2019-11-15T09:51:05-06:00 2018-12-31 520959934 ELLIN & TUCKER CHARTERED 400 EAST PRATT ST SUITE 200 BALTIMORE MD 21202 990 2018-01-01 521290067 KERALINK INTERNATIONAL INC KERA 8006081193 300 E LOMBARD STREET NO 1510 BALTIMORE MD 21202 SHELBY TYLER CONTROLLER 8006081193 2019-11-15 1 SUSAN KELLER P00245169 4107275735 2019-11-15 65.246.120.254 2019-11-15 10:16:56 ES P AB7DFB60C93AA1B331567231D7D48371795C5F56 444E16CE0829E05289B9DEB34A3C173321A2C313 2018 2020-03-31 21:24:44Z SHELBY TYLER 300 E LOMBARD STREET NO 1510 BALTIMORE MD 21202 27146655 0 X HTTPS://KLIVISION.ORG X 1983 MD FACILITATING DONATION, RETRIEVAL, TESTING AND PROCESSING OF HUMAN TISSUE FOR IMPLANTATION. 9 8 159 0 0 0 292918 317230 15700639 14980728 -176702 328464 433700 48750 16250555 15675172 50000 0 0 0 7101878 7740680 0 0 311616 11662693 12618621 18814571 20359301 -2564016 -4684129 23928215 17964000 9284881 8437814 14643334 9526186 X TO RELIEVE HUMAN SUFFERING BY FACILITATING THE DONATION, RETRIEVAL,PROCESSING AND EQUITABLE DISTRIBUTION OF OCULAR TISSUE FORTRANSPLANTATION, RESEARCH, EDUCATION AND OTHER MEDICAL NEEDSWORLDWIDE. 0 1 16560005 14980728 MEDICAL SERVICES OF EYE AND TISSUE BANKING INCLUDING THE RECOVERY,PROCESSING, ANALYSIS, TESTING, AND DISTRIBUTION OF DONATED OCULARTISSUES. 624555 INTERNATIONAL OPERATIONS 553927 RESEARCH - PROVIDING TISSUES FOR MEDICAL RESEARCH. 356278 PUBLIC HEALTH EDUCATION - EYE & TISSUE DONOR OUTREACH AND DONORADVOCACY. 356278 18094765 1 1 0 0 0 0 0 0 0 0 1 0 0 0 1 1 1 0 0 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 64 0 159 1 0 0 0 0 0 0 0 0 0 0 X 9 8 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 AL AK AR CA CO CT FL IL KS ME MD MA MI MN MS MO NH NM ND OH OK OR PA RI SC TN UT VA WV WI NC GA HI NJ X THE ORGANIZATION 8006081193 300 E LOMBARD STREET NO 1510 BALTIMORE MD 21202 JOHN GRANDE DIRECTOR 1.00 X 0 0 0 WALTER J STARK MD DIRECTOR 1.00 X 0 0 0 C RANDALL MILLS DIRECTOR 1.00 X 0 0 0 KAREN ORT DIRECTOR 1.00 X 0 0 0 ROBERTO PINEDA II MD DIRECTOR 1.00 X 0 0 0 ELLEN KOO MD DIRECTOR 1.00 X 0 0 0 C THOMAS VANGSNESS JR MD DIRECTOR 1.00 X 0 0 0 BRYAN VOSSEKUIL DIRECTOR 1.00 X 0 0 0 SAMUEL C YIU MD DIRECTOR 1.00 X 0 0 0 PAMELA HALL DIRECTOR 1.00 X 0 0 0 TESSIE SMITH DIRECTOR 1.00 X 0 0 0 HARRY CARMITCHEL CHAIRMAN 1.00 X X 0 0 0 DOUGLAS J FURLONG VICE CHAIRMAN, CEO/PRESIDENT 40.00 X X 371126 0 30774 JOHN F MILLER CFO, TREASURER/SECRETARY 40.00 X X 215925 0 23415 REBECCA JORGENSON COO 40.00 X 219602 0 16021 CONNIE JONES VP QUALITY REGULATORY & COMPLIANCE 40.00 X 209513 0 14790 THOMAS M BUCKLEY VP OPERATIONS 40.00 X 177376 0 8882 MAHMOOD FARAZDAGHI SENIOR VP INTERNATIONAL 40.00 X 187573 0 9010 KATHLEEN TERLIZZESE VP DEVELOPMENT 40.00 X 130837 0 5552 KRISTIN WALKER SENIOR FAMILY SERVICES COORDINATOR 40.00 X 115405 0 14056 1627357 0 122500 8 0 1 0 DPR CONSTRUCTION 1450 VETERANS BLVD REDWOOD CITY CA 94063 CONSTRUCTION 1474636 THE LIVING LEGACY FOUNDATION 1730 TWIN SPRINGS ROAD SUITE 200 BALTIMORE MD 21227 TISSUE PROCUREMENT 596250 BAUSCH & LOMB 50 TECHNOLOGY DRIVE IRVINE CA 92618 MEDICAL SUPPLIES 488336 NEW ENGLAND DONOR SERVICES 60 FIRST AVENUE WALTHAM MA 02451 TISSUE PROCUREMENT 486178 4 317230 317230 REIMB TISSUE HANDLING 900099 13500773 13500773 MANAGEMENT FEES 561000 1479955 1479955 14980728 221085 221085 11521908 56954 11471483 0 50425 56954 107379 107379 ANNUAL ASSESSMENTS 900099 48750 48750 48750 15675172 14980728 0 377214 X 876863 762871 87686 26306 5430715 4713874 553955 162886 252978 189733 58185 5060 693242 573527 108800 10915 486882 402838 70771 13273 90664 74302 16356 6 221705 166279 50992 4434 26971 20228 6473 270 5165213 5081903 81366 1944 3109549 2827416 246042 36091 240391 189579 47505 3307 854282 692134 155864 6284 651570 539418 106055 6097 186007 149078 31680 5249 450 353 93 4 1392176 1197109 189987 5080 358645 268984 82488 7173 OTHER BANK FEES 160280 120210 38468 1602 DUES & LICENSING 146765 106804 24326 15635 NEW EMPLOYEE EXPENSE 44665 36626 8039 0 LAUNDRY 34374 34374 0 0 -65086 -52875 -12211 20359301 18094765 1952920 311616 331810 2939073 2441723 754770 388296 482005 122737 10024115 3391156 5585323 6632959 13250708 7852902 10329 549674 149851 356333 43722 23928215 17964000 8432301 6625812 852580 1812002 9284881 8437814 X 14633334 9516186 10000 10000 14643334 9526186 23928215 17964000 -4684129 -433019 0 X X 0 1 X 0 0 X 141076 40134 44626 292918 317230 835984 47077532 27068296 8268683 15700639 14980728 113095878 47218608 27108430 8313309 15993557 15297958 113931862 0 27502410 2287893 2125382 1399028 33314713 27502410 2287893 2125382 1399028 33314713 80617149 510 20752 452 249389 221085 492188 510 20752 452 249389 221085 492188 5371 45955 106 433700 48750 533882 47224489 27175137 8313867 16676646 15567793 114957932 0.70130 0.58260 0.00430 0.00180 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 6089017 1164432 4924585 3935098 2226724 1708374 6632959 DUE TO AFFILIATE 771553 DEFERRED RENT 295185 DEFERRED ALLOWANCE 643862 CUSTOMER DEPOSITS 101402 1812002 X 15242153 -433019 -433019 15675172 0 15675172 20359301 0 20359301 0 20359301 PART X, LINE 2: KERALINK IS EXEMPT FROM FEDERAL AND STATE INCOME TAXES UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE. IN ADDITION, THE INTERNAL REVENUE SERVICE HAS DETERMINED KERALINK IS NOT A PRIVATE FOUNDATION WITHIN THE MEANING OF SECTION 509(A) OF THE CODE. KERALINK FOLLOWS THE PROVISIONS OF ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES UNDER THE INCOME TAXES TOPIC OF THE CODIFICATION. THE CODIFICATION REQUIRES THE EVALUATION OF TAX POSITIONS, WHICH INCLUDE MAINTAINING ITS TAX-EXEMPT STATUS AND THE TAXABILITY OF ANY UNRELATED BUSINESS INCOME, AND DOES NOT ALLOW RECOGNITION OF TAX POSITIONS WHICH DO NOT MEET A "MORE-LIKELY-THAN-NOT" THRESHOLD OF BEING SUSTAINED BY THE APPLICABLE TAX AUTHORITY. MANAGEMENT DOES NOT BELIEVE IT HAS TAKEN ANY TAX POSITIONS THAT WOULD NOT MEET THIS THRESHOLD. 1 EAST ASIA AND THE PACIFIC 0 0 PROGRAM SERVICES EYE TISSUE BANKING 248750 EUROPE 0 0 PROGRAM SERVICES EYE TISSUE BANKING 314310 MIDDLE EAST AND NORTH AFRICA 0 0 PROGRAM SERVICES EYE TISSUE BANKING 426600 SUB-SUHARAN AFRICA 0 0 PROGRAM SERVICES EYE TISSUE BANKING 10450 THE CARIBBEAN 0 0 PROGRAM SERVICES EYE TISSUE BANKING 2490 0 0 0 0 0 0 1002600 0 1002600 0 0 0 0 0 0 PART I, LINE 3: INTERNATIONAL PROGRAM EXPENSES THE ACCOUNTING SYSTEM USED DOES NOT TRACK EXPENDITURES BY REGION THEREFORE THE AMOUNTS LISTED IN PART I LINE 3 ARE ESTIMATES WHICH IN AGGREGATE ARE THE TOTAL OF INTERNATIONAL PROGRAM EXPENSES. X X X X X X 0 0 0 0 0 0 0 0 0 DOUGLAS J FURLONG VICE CHAIRMAN, CEO/PRESIDENT 371126 0 0 0 0 0 13329 0 17445 0 401900 0 0 0 JOHN F MILLER CFO, TREASURER/SECRETARY 211925 0 4000 0 0 0 7339 0 16076 0 239340 0 0 0 REBECCA JORGENSON COO 211602 0 8000 0 0 0 9000 0 7021 0 235623 0 0 0 CONNIE JONES VP QUALITY REGULATORY & COMPLIANCE 201513 0 8000 0 0 0 7989 0 6801 0 224303 0 0 0 THOMAS M BUCKLEY VP OPERATIONS 177376 0 0 0 0 0 7000 0 1882 0 186258 0 0 0 MAHMOOD FARAZDAGHI SENIOR VP INTERNATIONAL 187573 0 0 0 0 0 7400 0 1610 0 196583 0 0 0 FORM 990, PART III, LINE 3 IN FEBRUARY 2019 KERALINK INTERNATIONAL, INC. SOLD ITS CORNEAL U.S. BASED OPERATIONS AND RELATED ASSETS TO CORNEAGEN. GOING FORWARD, THE ORGANIZATION WILL BE FOCUSED EXCLUSIVELY ON DEVELOPING AND IMPLEMENTING INNOVATIVE PROGRAMS, PRODUCTS, AND SERVICES TO ELIMINATE CORNEAL BLINDNESS OUTSIDE THE U.S. IN LOW AND MIDDLE INCOME COUNTRIES (LMICS). FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 IS PREPARED BY AN INDEPENDENT ACCOUNTING FIRM AND REVIEWED BY THE CONTROLLER BEFORE FILING WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C PROCESS FOR MONITORING THE CONFLICT OF INTEREST POLICY ALL NEW EMPLOYEES OF THE ORGANIZATION ARE REQUIRED TO REVIEW AND ACKNOWLEDGE COMPLIANCE WITH THE ORGANIZATION'S CONFLICT OF INTEREST POLICY. OFFICERS, DIRECTORS, AND KEY EMPLOYEES OF THE ORGANIZATION ARE REQUIRED ANNUALLY TO REVIEW AND AFFIRM COMPLIANCE WITH THE POLICY. OFFICERS AND DIRECTORS ARE EXPECTED TO REPORT ANY ACTUAL OR POTENTIALLY MATERIAL CONFLICTS TO THE FULL BOARD OF DIRECTORS FOR REVIEW AND ACTION. ADDITIONALLY ACTUAL OR POTENTIAL CONFLICTS IDENTIFIED ON BEHALF OF ANY TISSUE BANK'S INTERNATIONAL EMPLOYEE WILL BE COMMUNICATED TO EXECUTIVE MANAGMENT FOR INVESTIGATION AND RESOLUTION. FORM 990, PART VI, SECTION B, LINE 15 PROCESS FOR DETERMINING TOP MANAGEMENT OFFICIAL COMPENSATION MEMBERS OF THE BOARD OF DIRECTORS (COMPENSATION COMMITTEE) CONDUCT AN EXECUTIVE COMPENSATION REVIEW ANNUALLY TO SET THE CEO'S COMPENSATION. THE COMPENSATION COMMITTEE INCORPORATES COMPENSATION SURVEY DATA, REVIEW OF FORM 990 FROM COMPANIES IN RELATED INDUSTRIES AND OF SIMILAR SIZE. MEASUREMENT OF BOARD SET PERFORMANCE OBJECTIVES ARE ALSO USED TO SET CEO'S ANNUAL COMPENSATION. THE ORGANIZATION'S CEO IS RESPONSIBLE FOR SETTING AND REVIEWING THE COMPENSATION OF KERALINK INTERNATIONAL, INC.'S SENIOR MANAGEMENT TEAM. MARKET COMPENSATION DATA, INDEPENDENT COMPENSATION ANALYSIS AND INDIVIDUAL PERFORMANCE AGAINST OPERATIONAL OBJECTIVES ARE ALL FACTORED INTO THE REVIEW. FORM 990, PART VI, SECTION C, LINE 19 DOCUMENTS ARE AVAILABLE UPON REQUEST. FORM 990, PART IX, LINE 11G PROFESSIONAL SERVICES MEDICAL: PROGRAM SERVICE EXPENSES 5,081,903. MANAGEMENT AND GENERAL EXPENSES 81,366. FUNDRAISING EXPENSES 1,944. TOTAL EXPENSES 5,165,213.